Spravato vs. Traditional Antidepressants: A St. Louis Provider’s Perspective

You’ve tried everything. Three different antidepressants, maybe four. You’ve given each one months to work, dealt with the side effects, adjusted the doses, added supplements. Your doctor keeps saying “let’s give it more time” or “let’s try this other one.” Meanwhile, you’re still struggling to get out of bed. Still canceling plans. Still wondering if relief will ever come.

If this sounds familiar, you’re not imagining things. You’re not a failure. You’re part of a significant group of people living with what doctors call treatment-resistant depression, and the statistics are more common than most realize. Research shows that roughly one-third of people with major depression don’t respond adequately to traditional antidepressants, even after multiple attempts. That’s millions of Americans stuck in a cycle of trial and error, watching months turn into years while waiting for something to finally work.

But here’s what’s changed in recent years. You now have options that weren’t available a decade ago. One of those options is Spravato, an FDA-approved nasal spray that works completely differently than the medications you’ve already tried. At Alive Health & Wellness in St. Louis, we’ve watched this treatment transform lives for patients who had nearly given up hope. This isn’t about replacing traditional antidepressants for everyone. It’s about understanding when a different approach makes sense and what that approach actually involves.

Understanding Traditional Antidepressants: How They Work and Why They Sometimes Don’t

Traditional antidepressants have been the foundation of depression treatment for decades, and for good reason. They help millions of people manage their symptoms and live fuller lives. Most of these medications fall into categories you’ve probably heard of: SSRIs like Prozac or Zoloft, SNRIs like Cymbalta or Effexor, or older classes like tricyclics and MAOIs.

These medications work by adjusting levels of neurotransmitters in your brain, primarily serotonin, norepinephrine, and sometimes dopamine. The theory goes that depression stems from imbalances in these chemical messengers, so boosting their availability should improve mood, energy, and overall functioning. For many people, this approach works reasonably well after finding the right medication and dose.

But there’s a catch that anyone who’s been through the process knows intimately. These medications take time to work, usually four to six weeks before you notice any real improvement. During that waiting period, you might deal with side effects like nausea, weight gain, sexual dysfunction, or emotional numbness. If that medication doesn’t work, you start over with another one, waiting another month or two to see if this one will be different. Some people cycle through five, six, or even more medications over the course of years.

The National Institute of Mental Health conducted a large study called STAR*D that revealed some sobering truths about this trial-and-error approach. With each successive medication attempt, the likelihood of achieving remission drops. By the time you’re on your third or fourth antidepressant, your chances of finding relief through traditional medications alone become significantly lower. The cumulative effect of this process isn’t just about the passage of time. It’s about the erosion of hope that comes with each failed attempt.

And here’s something that doesn’t get discussed enough: traditional antidepressants work primarily on the serotonin system, which means if your depression isn’t responding to that mechanism, trying five different medications that all work the same way probably won’t give you different results. It’s like trying to unlock a door with ten different keys that are all cut the same way. Eventually, you need a different type of key altogether.

This is where understanding treatment-resistant depression becomes critical. You’re not resistant to treatment. You’re resistant to treatments that work through a specific mechanism. Your brain chemistry might require a different approach, which is exactly what newer treatments like Spravato offer.

What Makes Spravato Different: A New Pathway to Relief

Spravato represents a fundamental shift in how we approach depression treatment. The active ingredient is esketamine, derived from ketamine, which has been used safely in medical settings for over 50 years. What makes it revolutionary isn’t that it’s new, it’s that it works through an entirely different mechanism than anything that came before it in depression treatment.

Instead of targeting serotonin receptors like traditional antidepressants, Spravato works on the glutamate system in your brain. Glutamate is the most abundant neurotransmitter in your nervous system and plays a crucial role in neural connectivity and plasticity. When depression takes hold, research suggests that key neural pathways become damaged or disconnected. Spravato helps restore these connections, potentially explaining why some people experience rapid improvements that weren’t possible with other medications.

The FDA approved Spravato in 2019 specifically for treatment-resistant depression, meaning it’s designed for people who haven’t responded to at least two different antidepressant trials. This wasn’t a casual approval. It came after extensive clinical trials showing that Spravato, when used alongside an oral antidepressant, produced significant improvements in depression symptoms compared to antidepressants alone.

One of the most striking differences is the timeline. While traditional antidepressants require weeks to show any benefit, some people notice improvements within hours or days of their first Spravato treatment. This doesn’t mean it works instantly for everyone, but the potential for rapid relief offers something that’s been missing for people who’ve suffered for years: hope that change is actually possible.

The treatment itself is straightforward. You self-administer the nasal spray under medical supervision at a certified clinic like Alive Health & Wellness. Each session takes about two hours because monitoring is required. You’re not sent home immediately after dosing. We watch for side effects, check your blood pressure, and make sure you’re stable before you leave. During the acute phase, you typically come twice a week for four weeks, then transition to weekly or less frequent maintenance dosing based on your response.

Here’s what matters most: Spravato isn’t marketed as a miracle cure. It’s a tool that works best when combined with an oral antidepressant and, ideally, therapy. The research backing its efficacy is solid, with studies published in reputable journals showing response rates that significantly exceed what’s achievable with standard treatments alone. The FDA’s approval wasn’t based on hope or theory. It was based on data showing real people getting real relief.

The Science Behind Both Approaches: What the Research Actually Shows

Let’s talk numbers, because when you’re making decisions about your mental health, you deserve to know what the evidence really says. Traditional antidepressants show response rates of around 50 to 60 percent in first-line treatment, meaning about half of people experience meaningful improvement. That sounds reasonable until you realize it also means half don’t respond adequately. For those who don’t respond to the first medication, the success rate drops with each subsequent trial.

The STAR*D study followed over 4,000 patients through multiple levels of antidepressant treatment. After one medication failed, only about 25 percent achieved remission with the second. By the fourth treatment attempt, that number dropped to around 15 percent. These aren’t abstract statistics. They represent the lived reality of people who spend years searching for relief through traditional approaches.

Spravato’s clinical trial data tells a different story for treatment-resistant populations. In pivotal studies, patients who received Spravato plus an oral antidepressant showed significantly greater improvement than those who received the oral antidepressant plus a placebo nasal spray. Response rates in some trials exceeded 60 percent among people who had already failed multiple treatments, a population where response rates to standard care typically hover around 20 to 30 percent.

The FDA’s announcement of Spravato’s approval highlighted its novel mechanism as a major factor in the decision. This wasn’t just another medication tweaking serotonin levels. It was the first truly new approach to depression in decades, offering a pathway for people who had exhausted other options.

Research published in the American Journal of Psychiatry and JAMA Psychiatry has continued to validate Spravato’s effectiveness. Long-term studies show that people who respond to Spravato can maintain those improvements with ongoing maintenance treatment. The relapse rates for people who continue treatment are significantly lower than for those who discontinue, suggesting that Spravato provides sustainable relief rather than temporary improvement.

But we can’t discuss the science without acknowledging what we don’t know yet. Spravato is still relatively new compared to medications that have been around for 30 or 40 years. We’re still learning about optimal dosing strategies, long-term outcomes beyond a few years, and which patient characteristics predict the best response. What we do know is encouraging, but medicine is built on ongoing research and refinement.

The mechanism of action is where things get particularly interesting. Traditional antidepressants increase the availability of existing neurotransmitters in the synaptic space between neurons. Spravato appears to promote neuroplasticity, essentially helping your brain form new connections and repair damaged pathways. Studies using brain imaging have shown changes in neural connectivity after ketamine treatment that weren’t observed with traditional antidepressants.

This difference in mechanism explains why Spravato can work for people who haven’t responded to other treatments. If your depression isn’t primarily driven by serotonin deficiency, boosting serotonin won’t fix the problem. But if your depression involves disrupted neural circuits, a treatment that promotes neuroplasticity might address the root cause more effectively.

Side Effects, Safety, and What to Really Expect

Every medication comes with potential side effects, and being honest about them is part of informed decision-making. Traditional antidepressants commonly cause issues like nausea, sleep disturbances, sexual dysfunction, weight gain, and emotional blunting. Some people tolerate these effects reasonably well. Others find them so problematic that the medication becomes untenable despite helping their mood.

Sexual dysfunction deserves special mention because it’s both common and significantly underreported. Studies suggest that 40 to 60 percent of people on SSRIs experience some degree of sexual side effects, ranging from decreased libido to difficulty achieving orgasm. For people in relationships or for whom sexual health is important to their quality of life, this side effect can be deal-breaking. Yet it often goes unaddressed in clinical settings because patients feel uncomfortable bringing it up and doctors don’t always ask.

Spravato’s side effect profile looks different. The most common effects include dissociation (feeling disconnected from your thoughts, feelings, or surroundings), dizziness, nausea, sedation, and increased blood pressure. These effects are typically most pronounced immediately after dosing and resolve within a couple of hours. This is why you remain at the clinic under observation. We’re not sending you home to deal with these effects alone.

Dissociation concerns some people when they first hear about it. It can feel strange or unsettling, like you’re watching yourself from outside your body or like your surroundings aren’t quite real. For most patients at Alive Health & Wellness, this sensation is temporary and becomes less intense with subsequent treatments. Some people even find it somewhat therapeutic, describing it as a break from the constant negative thoughts that characterize their depression.

The blood pressure issue requires careful monitoring but is manageable. We check your vitals before and after each dose. For people with uncontrolled hypertension or certain cardiovascular conditions, Spravato might not be appropriate, which is why thorough screening happens before starting treatment.

Unlike traditional antidepressants, Spravato doesn’t typically cause sexual dysfunction, weight gain, or the emotional numbing that some people describe on SSRIs. You’re not choosing between your mental health and other aspects of your quality of life. The tradeoff is different: temporary, acute effects during treatment sessions versus chronic, ongoing side effects with traditional medications.

The safety profile has been extensively studied both in clinical trials and in real-world use since approval. Abuse potential is a concern with any medication related to ketamine, which is why Spravato is only available through a restricted distribution program. You can’t pick it up at a regular pharmacy. It must be administered at a certified healthcare facility by trained providers. This REMS (Risk Evaluation and Mitigation Strategy) program ensures appropriate use and monitoring.

One concern that comes up frequently: can you become dependent on Spravato? The evidence suggests that when used as prescribed under medical supervision, the risk is low. The dissociative effects that some people find appealing in recreational ketamine use are generally not sought after by patients using Spravato for depression. You’re coming to a medical clinic for treatment, not chasing a high.

Who Should Consider Spravato: Making the Right Choice for Your Situation

Spravato isn’t for everyone, and that’s an important starting point. It’s specifically indicated for adults with treatment-resistant depression who have tried at least two different antidepressants without adequate response. If you’re just starting treatment for depression, traditional antidepressants remain the appropriate first-line approach. They work for many people, they’re more convenient, and they don’t require supervised administration.

But if you’ve been down the road of trying multiple medications over months or years, if you’ve dealt with debilitating side effects, if your doctor keeps suggesting “let’s try one more,” then Spravato might be worth discussing. Here are some scenarios where it particularly makes sense:

You’ve tried three or more antidepressants from different classes without significant improvement. You’ve given each one an adequate trial at therapeutic doses. You’re still experiencing symptoms that interfere with your work, relationships, or daily functioning.

Your depression includes acute suicidal thoughts. Research suggests Spravato may work particularly quickly for people experiencing suicidal ideation, potentially providing relief faster than traditional approaches. If you’re in crisis, this rapid action could be lifesaving. At Alive Health & Wellness, we take suicidal ideation treatment seriously and can assess whether Spravato is appropriate for your situation.

You’ve experienced intolerable side effects from multiple antidepressants. If sexual dysfunction, weight gain, or emotional numbing has made traditional medications untenable, Spravato’s different side effect profile might be more manageable.

You need relief faster than traditional medications can provide. If you’re at risk of losing your job, your relationship is suffering, or you simply can’t sustain another two-month wait to see if something works, Spravato’s potential for rapid response becomes particularly valuable.

You’re committed to the treatment protocol. Spravato requires coming to a clinic twice weekly initially, then transitioning to weekly or less frequent maintenance. Each visit takes about two hours. You need reliable transportation (you can’t drive yourself home) and the ability to commit to this schedule. If logistical barriers make this impossible, Spravato might not be practical regardless of how well it could work.

Who shouldn’t consider Spravato? People with certain cardiovascular conditions, uncontrolled high blood pressure, or a history of substance abuse disorders need particularly careful evaluation. Pregnancy and breastfeeding are also considerations that require discussion with your provider. The goal isn’t to exclude people but to ensure safety and appropriate use.

Insurance coverage varies, but many plans now cover Spravato for treatment-resistant depression when medical necessity is documented. The prior authorization process can be frustrating, requiring documentation of previous medication trials and symptom severity. At our St. Louis clinic, we help patients navigate this process because we believe access to effective treatment shouldn’t be derailed by administrative hurdles.

Real Outcomes: What Our St. Louis Patients Experience

Statistics matter, but they don’t tell the whole story. The patients we see at Alive Health & Wellness bring those numbers to life in ways that research papers can’t capture. They come to us exhausted from years of trying, skeptical that anything will be different, often at the urging of a family member who’s watched them suffer.

We’ve treated patients who hadn’t responded to five, six, or seven different antidepressants. One woman in her forties had spent fifteen years cycling through medications, each one either ineffective or causing side effects that made life harder rather than easier. She started Spravato therapy expecting nothing, but within three weeks she described feeling “like fog lifting.” Not perfect, not suddenly happy, just clearer and more capable of engaging with her life.

A teacher in his thirties had been on medical leave for depression. He’d tried three different SSRIs and two SNRIs over eighteen months. Nothing helped enough. He was facing the possibility of losing his career. After eight Spravato sessions, he returned to work. He’s maintained his improvement with maintenance dosing and describes the difference as “finally having access to my own brain again.”

These aren’t universal experiences. Not everyone responds this dramatically or this quickly. We’ve also treated patients who needed more time to see benefits or who ultimately found that Spravato helped but didn’t completely resolve their symptoms. Some people continue with a combination approach, using Spravato periodically while maintaining their oral antidepressant.

What distinguishes responders from non-responders isn’t always clear. Some patterns suggest that people with more acute, severe depression might respond better than those with longer, chronic courses. But there are plenty of exceptions. This is why medicine remains as much art as science, requiring individualized assessment and ongoing adjustment.

The practical aspects of treatment matter too. Coming to the clinic twice a week initially is demanding. Some patients struggle with the time commitment or the need to arrange transportation. But most people who respond to treatment find that the inconvenience fades in importance compared to the relief they experience. When you’ve been suffering for years, two hours twice a week becomes a small price for feeling like yourself again.

We also see people who don’t respond to Spravato, and that’s important to acknowledge. Maybe one in three patients don’t experience significant improvement, similar to the response rates with any individual antidepressant. For these patients, we explore other options, including IV ketamine therapy or other emerging treatments. The point isn’t that Spravato works for everyone. It’s that it works for some people for whom nothing else has, and that makes it worth trying.

The Treatment Process: From Evaluation to Ongoing Care

Starting Spravato isn’t as simple as picking up a prescription at the pharmacy, and that’s by design. The process begins with a comprehensive evaluation to determine if you meet the criteria for treatment-resistant depression and if Spravato is medically appropriate for you.

During the initial consultation at Alive Health & Wellness, we review your psychiatric history in detail. How many medications have you tried? At what doses? For how long? What side effects did you experience? We need to document that you’ve had adequate trials of at least two antidepressants, meaning therapeutic doses for sufficient duration. We also assess your current symptoms, risk factors, and overall health status.

Medical screening includes checking your cardiovascular health since Spravato can raise blood pressure. We review any history of substance use, discuss your current medications, and make sure there aren’t any contraindications that would make treatment unsafe. This isn’t about creating barriers. It’s about ensuring we can offer treatment safely and effectively.

If you’re a good candidate, we work with your insurance company to obtain authorization. This step can take a few weeks and requires submitting documentation of your treatment history and current symptoms. It’s frustrating when you’re ready to start, but most insurance companies do ultimately approve coverage when medical necessity is clear.

Once approved, we schedule your first treatment session. You’ll need to arrange for someone to drive you home, as you can’t operate a vehicle for the rest of the day after dosing. When you arrive, we check your blood pressure and review what to expect. You self-administer the nasal spray under our supervision, following specific instructions about timing and technique to ensure proper absorption.

After dosing, you rest in a comfortable, quiet space. Some people prefer to close their eyes and relax. Others find it helpful to have calming music or nature sounds. The dissociative effects typically peak within 30 to 40 minutes and gradually resolve over the next hour or so. We monitor you throughout, checking your blood pressure periodically and making sure you’re comfortable.

You’ll stay for about two hours total. Before you leave, we confirm your blood pressure has returned to baseline and that you feel stable enough to go home with your driver. Most people feel tired afterward and benefit from resting for the remainder of the day. By the next morning, the acute effects have completely resolved.

The initial treatment phase involves twice-weekly sessions for four weeks. This induction period is when you’re most likely to notice improvement. After that, we assess your response and transition to weekly maintenance dosing, eventually spacing out to every two weeks or monthly depending on how you’re doing.

Ongoing monitoring is crucial. Depression treatment isn’t something you do once and forget about. We track your symptoms, adjust your dosing schedule as needed, and coordinate with your psychiatrist or primary care provider who manages your oral antidepressant. This collaborative approach gives you the best chance of sustained improvement.

Cost, Insurance, and Access in St. Louis

Let’s address the elephant in the room: Spravato is expensive. Without insurance, the medication alone costs thousands of dollars per month. This makes affordability a legitimate barrier for many people who could benefit from treatment.

The good news is that most major insurance plans cover Spravato for FDA-approved indications when medical necessity is documented. Medicare and many state Medicaid programs also provide coverage. The challenge is navigating the prior authorization process, which requires detailed documentation of previous treatment failures and current symptom severity.

At Alive Health & Wellness, we handle much of this administrative work on behalf of patients. We submit the necessary documentation, work with insurance companies to address any questions or denials, and persist through the appeals process when needed. It’s not quick or easy, but it’s part of ensuring access to treatment.

For patients without insurance coverage or with significant out-of-pocket costs even with insurance, the manufacturer offers a patient assistance program. This can significantly reduce costs for qualifying individuals, though eligibility requirements and benefit amounts vary.

The question of whether Spravato is “worth it” financially depends on your individual situation. If you’ve been unable to work due to depression, the cost of ongoing disability may exceed the cost of treatment. If your relationships are suffering or your quality of life is severely impaired, the value of improvement can’t be measured purely in dollars. These are deeply personal calculations that each patient has to make based on their own circumstances.

Access in St. Louis is improving as more providers become certified to offer Spravato. The medication can only be dispensed through a restricted distribution program, meaning not every clinic can provide it. Alive Health & Wellness is certified and experienced in administering Spravato, and we’re located in Kirkwood for convenient access from throughout the St. Louis metro area.

Transportation can be a practical barrier since you can’t drive yourself home after treatment. Some patients have family members who can provide rides. Others use ride-sharing services or arrange for friend support. During the intensive twice-weekly phase, coordinating transportation for eight sessions over four weeks requires planning, but most patients find ways to make it work.

Making the Decision: Questions to Ask Your Provider

If you’re considering Spravato, having a thorough discussion with a qualified provider is essential. Here are questions worth asking:

How many antidepressants do I need to have tried before Spravato is appropriate? The FDA indication requires two adequate trials, but your provider should explain what constitutes an “adequate trial” and review your specific medication history.

What are my chances of responding based on my particular situation? No provider can guarantee outcomes, but they should be able to discuss factors that might predict better or worse response based on your symptoms, history, and overall health.

How quickly might I notice improvement? While some people experience rapid relief, others need several weeks. Setting realistic expectations helps avoid disappointment.

What happens during a treatment session? Understanding the practical details reduces anxiety about the unknown.

What side effects should I watch for? Knowing what’s normal versus what requires immediate attention helps you stay safe.

How long will I need treatment? Is this a short-term intervention or an ongoing maintenance therapy? Most people who respond to Spravato need maintenance treatment to sustain improvement, but the frequency can often be reduced over time.

What happens if Spravato doesn’t work for me? Having a plan B is part of good medical care. Your provider should discuss other options if Spravato isn’t effective.

How much will this cost with my insurance? Getting clarity about financial responsibility upfront prevents surprises.

Can I continue my current antidepressant? Spravato is used in conjunction with an oral antidepressant, not as a replacement.

Are there lifestyle changes or other treatments I should combine with Spravato? Medication works best as part of a comprehensive approach including therapy, exercise, sleep hygiene, and other evidence-based strategies.

The Bottom Line: Different Tools for Different Situations

Traditional antidepressants remain valuable and appropriate first-line treatments for depression. They work for millions of people, they’re convenient, and decades of research support their safety and efficacy. If you haven’t tried them yet, they’re likely where your treatment should start.

But if you’ve already gone down that road without finding relief, Spravato offers something fundamentally different. Not another variation on the same theme, but a new mechanism targeting different brain systems. For people with treatment-resistant depression in St. Louis, this means hope where there might not have been hope before.

The choice between sticking with traditional approaches and trying Spravato isn’t always clear-cut. It depends on how many treatments you’ve tried, how severely your symptoms affect your life, whether you can manage the practical requirements of Spravato treatment, and what your individual risk-benefit calculation looks like.

What’s clear is that you don’t have to resign yourself to suffering indefinitely. Medical science continues advancing, and treatments that didn’t exist a decade ago are now accessible to people who need them. At Alive Health & Wellness, we’ve seen these advances translate into real improvements for real people who had nearly lost hope.

If you’re in the St. Louis area and you’ve been struggling with depression that hasn’t responded to traditional treatments, a conversation about Spravato might be worth having. It’s not the right choice for everyone, but for some people, it’s the choice that finally makes a difference.

 

Alive Health & Wellness
125 W Argonne Dr, Kirkwood, MO 63122
(636) 736-0966

 

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Spravato (esketamine) is a prescription medication approved by the FDA for treatment-resistant depression in adults. Treatment should only be pursued under the guidance of qualified healthcare providers. If you are experiencing a mental health emergency or having thoughts of suicide, please call 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room immediately. Individual results may vary, and not all patients respond to Spravato treatment. All medications carry potential risks and side effects that should be discussed with your healthcare provider.